Strategies to enhance the efficacy of FGF2-based therapies for skin wound healing

Basic fibroblast growth factor (FGF2 or bFGF) is critical for optimal wound healing. Experimental studies show that local application of FGF2 is a promising therapeutic approach to stimulate tissue regeneration, including for the treatment of chronic wounds that have a low healing potential or are characterised by a pathologically altered healing process. However, the problem of low efficiency of growth factors application due to their rapid loss of biological activity in the aggressive proteolytic environment of the wound remains. Therefore, ways to preserve the efficacy of FGF2 for wound treatment are being actively developed. This review considers the following strategies to improve the effectiveness of FGF2-based therapy: (1) use of vehicles/carriers for delivery and gradual release of FGF2; (2) chemical modification of FGF2 to increase the stability of the molecule; (3) use of genetic constructs encoding FGF2 for de novo synthesis of protein in the wound. In addition, this review discusses FGF2-based therapeutic strategies that are undergoing clinical trials and demonstrating the efficacy of FGF2 for skin wound healing.

Alkanethiol Molecular Barriers for Controlling Small Molecule Release Kinetics from a Microgel-Based Reservoir Device

Poly(N-isopropylacrylamide)-co-acrylic acid microgel-based reservoir devices were constructed by "sandwiching" a single layer of microgels between two thin Au layers (all on a glass support). The microgels were loaded with the model drug crystal violet (CV) utilizing the electrostatic interactions between deprotonated acrylic acid (AAc) and the positively charged CV; release can be triggered from the microgels by neutralizing the deprotonated AAc groups at acidic conditions. Alkanethiols of different alkyl chain lengths and polarities were immobilized on the upper Au layer of the device, and the release rate of the model drug CV from the microgel layer, after acid neutralization, was assessed. We found that the CV release rate was the highest when the alkyl chain length was short and contained a hydrophilic moiety. Conversely, the release rate was hindered by the presence of thiols with long alkyl chain lengths and with no hydrophilic moiety. We explain this phenomenon by quantifying the thiol's ability to hinder acid penetration into the microgel layer, and the ability of free CV to pass through the upper Au layer and into the solution. Utilizing various thiols and mixed thiol layers, we are able to tune release profiles from these reservoir devices to potentially achieve array devices with precisely tuned small molecule release profiles.

Topographically Defined, Biodegradable Nanopatterned Patches to Regulate Cell Fate and Acceleration of Bone Regeneration

If only allowed to proceed naturally, the bone-healing process can take several weeks, months, or even years depending on the injury size. In terms of bone-healing speed, many studies have been conducted investigating the deliverance of various growth factors of implantable biomaterials to shorten the time for bone regeneration. However, there may be side effects such as nerve pain, infection, or ectopic bone formation. As an alternative method, we focused on biophysical guidance, which provided similar topographical cues to the cellular environment to recruit host cells for bone defect healing. In this study, we hypothesized that aligned nanotopographical features have enhanced osteoblast recruitment, migration, and differentiation without external stimuli. We designed and fabricated a biodegradable poly(lactic- co-glycolic acid) nanopatterned patch using simple solvent casting and capillary force lithography. We confirmed that a biodegradable nanopatterned patch (BNP) accelerated the migration of osteoblasts according to the orientation of the patterned direction. These highly aligned osteoblasts may contribute to in vitro osteogenic differentiation, such as alkaline phosphate activity, mineralization, and calcium deposition, compared to the biodegradable flat patch (BFP). To demonstrate bone defect healing by BNP guidance in vivo, we implanted either whole or bridge BNP on the critical size defect of mouse calvarial ( ø 4 mm) or tibia bone (3 × 7 mm²). Only the BNP-treated group showed faster new bone formation and compact bone regeneration at the calvarial or tibia bone defect area compared to BFP at 4 or 8 weeks. Bridge BNP guided, in particular, the regeneration of new bone formation along the parallel direction of nanopatterned substrates. Here, we show that a BNP with biophysical guidance should be suitable for use in bone tissue regeneration through accelerated migration of the intact host cell.